2026 Johannes H. Schulte: Biology and Biochemistry Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Biology and Biochemistry	62	10655	9835	767	719	299	16369

Overview

Johannes H. Schulte is affiliated with Charité - University Medicine Berlin in Germany. Their research primarily spans the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with particular focus on Neurology, Molecular Biology, Oncology, Genetics, and Cancer Research.

The scientist's main research topics include:

Neuroblastoma Research and Treatments
Cancer, Hypoxia, and Metabolism
Cancer therapeutics and mechanisms
CAR-T cell therapy research
Virus-based gene therapy research
Hematopoietic Stem Cell Transplantation
Cytomegalovirus and herpesvirus research

Johannes H. Schulte has contributed to several recent papers, including:

Extrachromosomal DNA is associated with oncogene amplification and poor outcome across multiple cancers, 2020, Nature Genetics
Enhancer hijacking determines extrachromosomal circular MYCN amplicon architecture in neuroblastoma, 2020, Nature Communications
Spatial and temporal intratumour heterogeneity has potential consequences for single biopsy-based neuroblastoma treatment decisions, 2021, Nature Communications
Accelerating drug development for neuroblastoma: Summary of the Second Neuroblastoma Drug Development Strategy forum from Innovative Therapies for Children with Cancer and International Society of Paediatric Oncology Europe Neuroblastoma, 2020, European Journal of Cancer
Parallel sequencing of extrachromosomal circular DNAs and transcriptomes in single cancer cells, 2023, Nature Genetics

Frequent co-authors of Johannes H. Schulte include Angelika Eggert, Anton G. Henssen, Hedwig E. Deubzer, Peter Lang, and Annette Künkele.

Publications have frequently appeared in venues such as bioRxiv (Cold Spring Harbor Laboratory), Frontiers in Immunology, Nature Communications, Cancers, and the Journal of Clinical Oncology.

In addition to journal articles, Johannes H. Schulte has published a book titled Die hoheitliche Einbindung sachverständiger Stellen in naturwissenschaftlich-technisch komplexen Zulassungsverfahren, published by Duncker & Humblot in 2020.

Best Publications

The landscape of genomic alterations across childhood cancers

Susanne N. Gröbner;Barbara C. Worst;Joachim Weischenfeldt;Joachim Weischenfeldt;Ivo Buchhalter

1562
Citations
Stabilization of N-Myc Is a Critical Function of Aurora A in Human Neuroblastoma

Tobias Otto;Sebastian Horn;Markus Brockmann;Ursula Eilers

607
Citations
Telomerase activation by genomic rearrangements in high-risk neuroblastoma

Martin Peifer;Falk Hertwig;Frederik Roels;Daniel Dreidax

581
Citations
Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations

Thomas F Eleveld;Derek A Oldridge;Virginie Bernard;Jan Koster

537
Citations
Lysine-Specific Demethylase 1 Is Strongly Expressed in Poorly Differentiated Neuroblastoma: Implications for Therapy

Johannes H. Schulte;Soyoung Lim;Alexander Schramm;Nicolaus Friedrichs

500
Citations
LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression

Jan J Molenaar;Raquel Domingo-Fernández;Marli E Ebus;Sven Lindner

418
Citations
Extrachromosomal DNA is associated with oncogene amplification and poor outcome across multiple cancers.

Hoon Kim;Nam-Phuong Nguyen;Kristen Turner;Sihan Wu

386
Citations
The miR-17-92 MicroRNA Cluster Regulates Multiple Components of the TGF-β Pathway in Neuroblastoma

Pieter Mestdagh;Anna-Karin Bostrom;Francis Impens;Erik Fredlund;Erik Fredlund

360
Citations
Mutational dynamics between primary and relapse neuroblastomas

Alexander Schramm;Johannes Köster;Johannes Köster;Yassen Assenov;Kristina Althoff

348
Citations
Meta-analysis of Neuroblastomas Reveals a Skewed ALK Mutation Spectrum in Tumors with MYCN Amplification

Sara De Brouwer;Katleen De Preter;Candy Kumps;Piotr Zabrocki

320
Citations
Next-generation personalised medicine for high-risk paediatric cancer patients – The INFORM pilot study

Barbara C. Worst;Barbara C. Worst;Cornelis M. van Tilburg;Gnana Prakash Balasubramanian;Petra Fiesel;Petra Fiesel

312
Citations
MYCN regulates oncogenic MicroRNAs in neuroblastoma.

Johannes H. Schulte;Sebastian Horn;Tobias Otto;Birgit Samans

309
Citations
A mechanistic classification of clinical phenotypes in neuroblastoma

Sandra Ackermann;Sandra Ackermann;Maria Cartolano;Barbara Hero;Anne Welte;Anne Welte

286
Citations
Extrachromosomal circular DNA drives oncogenic genome remodeling in neuroblastoma

Richard P. Koche;Elias Rodriguez-Fos;Konstantin Helmsauer;Martin Burkert;Martin Burkert

254
Citations
The Expanding World of N-MYC–Driven Tumors

David S. Rickman;Johannes H. Schulte;Martin Eilers

246
Citations
Deep sequencing reveals differential expression of microRNAs in favorable versus unfavorable neuroblastoma

Johannes H. Schulte;Tobias Marschall;Marcel Martin;Philipp Rosenstiel

220
Citations
Histone deacetylase 10 promotes autophagy-mediated cell survival

Ina Oehme;Jan Peter Linke;Barbara C. Böck;Till Milde;Till Milde

214
Citations
Lysine-specific demethylase 1 restricts hematopoietic progenitor proliferation and is essential for terminal differentiation.

A Sprüssel;J H Schulte;S Weber;M Necke

208
Citations
Targeted expression of mutated ALK induces neuroblastoma in transgenic mice.

Lukas C Heukamp;Theresa Thor;Alexander Schramm;Katleen De Preter

196
Citations
A mechanistic classification of clinical phenotypes in neuroblastoma

S Ackermann;M Cartolano;B Hero;A Roderwieser

0
Citations